<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT944-9521</title>
	</head>
	<body>
		<main>
			<p>941115 FT  15 NOV 94 / International Company News: FTC to probe SmithKline purchase US anti-trust authorities have launched an investigation into SmithKline Beecham's Dollars 2.3bn acquisition earlier this year of Diversified Pharmaceutical Services, a US drug distributor, writes Richard Waters in New York. The enquiry, by the Federal Trade Commission, follows its intervention last month in Eli Lilly's purchase of PCS, a pharmacy benefit management (PBM) company. After reaching a compromise with Lilly, the FTC said it would continue to look closely at vertical integration in the pharmaceuticals industry, which has seen some of the biggest distributors fall into the hands of manufacturers. The Diversified acquisition was completed in May, several months after Merck paid Dollars 6.7bn for Medco Containment Services, another PBM. A Merck spokesman could not immediately be reached, but that acquisition is also believed to be under review. SmithKline said that it had been notified by the FTC of its interest, and added that 'the procedures that we have in place are responsive to any reasonable concerns the FTC or other government representatives may have.'</p>
		</main>
</body></html>
            